Attention and Eye Movement in Parkinson's Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

February 29, 2028

Study Completion Date

August 31, 2028

Conditions
Essential TremorParkinson's Disease (PD)
Interventions
OTHER

Normal therapeutic DBS

Participants will receive deep brain stimulation delivered at the clinically determined therapeutic frequency and current over approximately 20 min.

OTHER

Reduced current DBS

Participants will receive deep brain stimulation delivered at the clinically determined therapeutic frequency and reduced (50%) current over approximately 20 minutes.

OTHER

Reduced frequency DBS

Participants will receive deep brain stimulation delivered at the clinically determined therapeutic current and reduced (4 Hz) frequency over approximately 20 min.

Trial Locations (1)

68198

University of Nebraska Medical Center, Omaha

All Listed Sponsors
collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

University of Nebraska

OTHER

NCT06899022 - Attention and Eye Movement in Parkinson's Disease | Biotech Hunter | Biotech Hunter